PubRank

S Lévy

Author PubWeight™ 40.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001 3.65
2 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001 3.34
3 ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001 3.13
4 Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1998 1.47
5 Influence of residual myocardial ischaemia on induced ventricular arrhythmias following a first acute myocardial infarction. Eur Heart J 2001 1.43
6 [Value of systematic preventive antibiotherapy in cardiac pacemaker implantation]. Ann Cardiol Angeiol (Paris) 1991 1.08
7 Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006 1.07
8 International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 2003 1.06
9 Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol 2000 1.06
10 Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology 1997 1.04
11 Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997 0.97
12 [Heart perforation following transvenous implantation of a cardiac pacemaker]. Presse Med 1999 0.96
13 Incidence of perforation and other mechanical complications during dual active fixation. Pacing Clin Electrophysiol 1996 0.95
14 Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Thromb Haemost 1999 0.90
15 [Wolff-Parkinson-White syndrome. Correlation between the results of electrophysiological investigation and exercise tolerance testing on the electrical aspect of preexcitation]. Arch Mal Coeur Vaiss 1979 0.89
16 External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks. Europace 2001 0.88
17 Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia 1997 0.88
18 Genetics of the PTS components in Escherichia coli K-12. FEMS Microbiol Rev 1989 0.86
19 Internal low-energy cardioversion: a therapeutic option for restoring sinus rhythm in chronic atrial fibrillation after failure of external cardioversion. Europace 1999 0.84
20 [Percutaneous electric interruption of normal auriculoventricular conduction. Analysis of French cases]. Arch Mal Coeur Vaiss 1986 0.82
21 Treatment of hepatitis C patients with normal aminotransferases levels. Clin Liver Dis 1999 0.81
22 Catheter ablation using very high frequency current: effects on the atrioventricular junction and ventricular myocardium in sheep. Europace 2002 0.81
23 [In vitro malignant transformation of fetal hamster brain cells by benzo (a) pyrene]. C R Acad Sci Hebd Seances Acad Sci D 1976 0.81
24 Pacing-induced alternate Wenckebach periods: incidence and clinical significance. Pacing Clin Electrophysiol 1979 0.80
25 Nodular regenerative hyperplasia of the liver associated with a Factor V Leiden mutation. Eur J Gastroenterol Hepatol 1998 0.80
26 Dietary fish oil promotes positive inotropy of ouabain in the rat heart. Am J Physiol 1999 0.79
27 Cholesterol and omega-3 fatty acids inhibit Na, K-ATPase activity in human endothelial cells. Atherosclerosis 1999 0.79
28 Specific up-regulation of mitochondrial F0F1-ATPase activity after short episodes of atrial fibrillation in sheep. J Cardiovasc Electrophysiol 2000 0.78
29 Electrophysiology of tiapamil in humans. Cardiology 1982 0.78
30 [Supraventricular tachycardia induced by effort and by catecholamines]. Arch Mal Coeur Vaiss 1985 0.78
31 [Complex ventricular extrasystole. Value of technics of programmed electric stimulation]. Arch Mal Coeur Vaiss 1987 0.78
32 Remote occurrence of high degree heart block following failure of transcatheter AV junctional ablation: incidence and clinical significance. Pacing Clin Electrophysiol 1987 0.77
33 [Parkinson syndrome, a possible adverse effect of calcium inhibitors]. Arch Mal Coeur Vaiss 1992 0.75
34 Is the implantable cardioverter-defibrillator cost-effective? Eur Heart J 1996 0.75
35 Effects of digoxin on chemoreflex in patients with chronic heart failure. Cell Mol Biol (Noisy-le-grand) 2001 0.75
36 A new method for evaluating the effect of antiarrhythmic drugs on atrioventricular nodal conduction. Br Heart J 1986 0.75
37 Cardioversion of chronic atrial fibrillation-towards a more aggressive approach. Eur Heart J 2000 0.75
38 Trans-septal catheterization: a new frontier in clinical electrophysiology? Eur Heart J 1998 0.75
39 Intravenous digoxin: still the drug of choice for acute termination of atrial fibrillation? Eur Heart J 1997 0.75
40 Atrioventricular junctional ablation and pacing for paroxysmal atrial fibrillation: the Barcelona recommendations. Europace 1999 0.75
41 [Atrioventricular "sequential" stimulation by implantable "bifocal" stimulator]. Arch Mal Coeur Vaiss 1976 0.75
42 [Importance of sequential atrioventricular pacing in obstructive myocardiopathy with atrioventricular block]. Arch Mal Coeur Vaiss 1979 0.75
43 [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects]. Arch Mal Coeur Vaiss 1981 0.75
44 [Changes in homeostasis during surgical liver resection]. Ann Fr Anesth Reanim 1999 0.75
45 Parkinson's disease: a new risk factor for gallstone disease? J Hepatol 1995 0.75
46 Partial atrial electrical standstill: report of three cases and review of clinical and electrophysiological features. Eur Heart J 1980 0.75
47 [Sequential double demand programmable stimulation in the treatment of resistant supraventricular tachycardia. Long-term results]. Arch Mal Coeur Vaiss 1983 0.75
48 [Apropos of a government memorandum of 29 December 1994 and a 16 March 1995 ordinance relative to the use of disposable sterile medical equipment]. Arch Mal Coeur Vaiss 1995 0.75
49 Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentry. Europace 2001 0.75
50 [Electrophysiologic mechanisms of electric ischemia, electric lesions, and electric necrosis: programmed teaching]. Coeur Med Interne 1975 0.75
51 Intrapulmonary artery coiling of a permanent pacing lead. Clin Cardiol 1994 0.75
52 Electrocardiographic characteristics of the escape rhythm in transient complete atrioventricular block induced by transcatheter electrical ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1988 0.75
53 Plasma beta-endorphin and adenosine concentration in pulmonary hypertension. Am J Cardiol 2000 0.75
54 [Materno-foetal transfer of anti-HLA antibodies. Study by using LDA test (author's transl)]. Nouv Rev Fr Hematol 1978 0.75
55 [Unstable angina and single vessel stenosis of the anterior interventricular artery. Evaluation of the threatened myocardium. Therapeutic implications]. Ann Cardiol Angeiol (Paris) 1983 0.75
56 Left anterior fascicular block secondary to coronary artery spasm. Eur Heart J 1981 0.75
57 [Cardiac Doppler in the selection of patients for aortic valvuloplasty. Comparison with data of phonomecanograms]. Ann Cardiol Angeiol (Paris) 1988 0.75
58 [Ventricular arrhythmia following repair of Fallot's tetralogy. Apropos of 59 cases]. Arch Mal Coeur Vaiss 1985 0.75
59 Membrane markers, karyotypic abnormalities, ultrastructure and functional properties of lymphocytes in a case of 'D-cell' chronic lymphatic leukemia. Leuk Res 1984 0.75
60 [Coronary angioplasty immediately after coronary recanalization in the acute phase of myocardial infarct]. Ann Cardiol Angeiol (Paris) 1983 0.75
61 [Electrophysiological properties of the heart in hypertension (author's transl)]. Ann Cardiol Angeiol (Paris) 1980 0.75
62 [Indications of beta-blockers in paediatric cardiology (author's transl)]. Ann Cardiol Angeiol (Paris) 1982 0.75
63 Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clin Microbiol Infect 2014 0.75
64 [Long-term treatment of arrhythmias with fenoxedil chlorhydrate]. Arch Mal Coeur Vaiss 1983 0.75
65 [Occlusive spasm of a coronary artery not treated during angioplasty. Apropos of a case]. Ann Cardiol Angeiol (Paris) 1993 0.75
66 [Recommendations on the practice of intracavitary diagnostic methods and treatment of cardiac arrhythmias. Diagnostic electrophysiology; interventional electrophysiology; permanent cardiac stimulation; automatic implantable defibrillators]. Arch Mal Coeur Vaiss 1998 0.75
67 [Treatment of recurrent ventricular tachycardia with hydroquinidine. Evaluation of its efficacy with electrophysiological technics]. Arch Mal Coeur Vaiss 1985 0.75
68 [Electro-mechanical dissociation concomitant with myocardial reperfusion in the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss 1987 0.75
69 [Prevalence of alcoholic diseases. At a teaching hospital of the Paris suburbs]. Presse Med 1990 0.75
70 [Hereditary resistance to vitamin K antagonists. Apropos of a case]. Arch Mal Coeur Vaiss 1999 0.75
71 [Coronary occlusion immediately following a successful coronary angioplasty. Treatment by repeat angioplasty]. Ann Cardiol Angeiol (Paris) 1985 0.75
72 [Reduction of ventricular tachycardia by programmed electric stimulation. Clinical implications]. Arch Mal Coeur Vaiss 1987 0.75
73 [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study]. Arch Mal Coeur Vaiss 1985 0.75
74 [Materno-foetal transfer of anti-HLA antibodies. Study by using LDA test (author's transl)]. Nouv Rev Fr Hematol 1979 0.75
75 [Exercise test in isolated anomalies of auriculo-ventricular conduction in children and adolescents. Value in idiopathic auriculo-ventricular blocks and ventricular pre-excitation syndromes]. Arch Mal Coeur Vaiss 1984 0.75
76 [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation]. Ann Cardiol Angeiol (Paris) 1993 0.75
77 [Wolff-Parkinson-White syndrome. Behavior during exercise testing limited by symptoms]. Arch Mal Coeur Vaiss 1979 0.75
78 Transvenous cardioversion of atrial fibrillation using low-energy shocks. J Interv Card Electrophysiol 1997 0.75
79 [Treatment of rhythm disorders by fenoxedil hydrochloride]. Arch Mal Coeur Vaiss 1976 0.75
80 Cirrhosis: a new, but expected cause of biliary sludge. Alcohol Clin Exp Res 1997 0.75
81 [Implantable ventricular defibrillator. Systematic induction of ventricular arrhythmia is not useful except for implantation]. Arch Mal Coeur Vaiss 1999 0.75
82 [Pharmacological treatment of ventricular tachycardia]. Arch Mal Coeur Vaiss 1993 0.75
83 Inducible ventricular arrhythmias and patency of infarct-related artery in survivors of acute myocardial infarction. Clin Cardiol 2001 0.75
84 [Isolated left anterior hemiblock during attacks of angina pectoris]. Arch Mal Coeur Vaiss 1978 0.75
85 [Idiopathic auriculo-ventricular block in young patients. Value of stress testing and the atropine test for the localization of the conduction disorder]. Arch Mal Coeur Vaiss 1982 0.75
86 [Comparative effects of anti-arrhythmia agents on ventricular refractory period and prevention of ventricular tachycardia induced by stimulation]. Arch Mal Coeur Vaiss 1992 0.75
87 [Importance of estimation of unconjugated bilirubin not linked to albumin in the new born and premature jaundiced baby]. Ann Pediatr (Paris) 1977 0.75
88 [Recommendations for good practice of intracavitary techniques for diagnosis and treatment of cardiac arrhythmia. Diagnostic electrophysiology; interventional electrophysiology; permanent cardiac stimulation; implantable automatic defibrillators]. Arch Mal Coeur Vaiss 1994 0.75
89 [Postprandial bidirectional tachycardia]. Arch Mal Coeur Vaiss 1982 0.75
90 [Atrioventricular block at nodal and infrahissian level during atrial tachycardia. Apropos of a case]. Arch Mal Coeur Vaiss 1992 0.75
91 Torsades de pointes. A clearly defined syndrome or an electrocardiographic curiosity? Int J Cardiol 1985 0.75
92 [Paroxysmal supraventricular tachycardia with complete atrio-ventricular block or dissociation]. Arch Mal Coeur Vaiss 1979 0.75
93 [Total or partial electrical interruption of the atrioventricular pathway. Evaluation of clinical results and indications]. Arch Mal Coeur Vaiss 1986 0.75
94 [Percutaneous venoplasty for the implantation of a dual-chamber cardiac pacemaker]. Arch Mal Coeur Vaiss 1994 0.75
95 [Automobile drivers' licensing and heart rhythm disorders. On what criteria should recommendations be bases?]. Arch Mal Coeur Vaiss 1998 0.75
96 [Wolff-Parkinson-White syndrome after 50 yars of age. Clinical and electrophysiological data]. Arch Mal Coeur Vaiss 1980 0.75
97 [Hemopericardium after coronary recanalization with streptokinase in the acute phase of myocardial infarction. Drainage and early aortocoronary bypass on the 4th day]. Arch Mal Coeur Vaiss 1983 0.75
98 [Right bundle-branch block with left hemiblock in the acute phase of myocardial infarct. Prognosis and role of cardiac pacing]. Arch Mal Coeur Vaiss 1975 0.75
99 [Wolff-Parkinson-White syndrome. Outcome of patients treated with anti-arrhythmia agents from data of electrophysiological examinations]. Arch Mal Coeur Vaiss 1988 0.75
100 [Carcinoid cardiopathy: value of ultrasonography and MRI. Apropos of a case related to bronchial tumor. Review of the literature]. Ann Cardiol Angeiol (Paris) 1989 0.75
101 Internal cardioversion. Is it needed? How best to perform it. Europace 2001 0.75
102 Exercise testing in the Wolff-Parkinson-White syndrome. Am J Cardiol 1981 0.75
103 [Interview with S. Lévy. Apropos of recommendations on defibrillators. Interview by M. Hérida]. Presse Med 1998 0.75
104 Retrograde (ventriculoatrial) conduction. Pacing Clin Electrophysiol 1983 0.75
105 [In vitro malignant transformation of hamster lung cells by 2-chlorobutadiene]. C R Seances Acad Sci D 1979 0.75
106 [Intravenous sotalol in the acute treatment of supraventricular tachycardias]. Arch Mal Coeur Vaiss 1986 0.75
107 [Systematic serodiagnosis of rubella in pregnancy and post-partum vaccination (HPV 77 vaccine)]. Gynecol Obstet (Paris) 1970 0.75
108 [Radiofrequency ablation of resistant atrial flutter: a new anatomical approach]. Arch Mal Coeur Vaiss 1997 0.75
109 [Coronarography by percutaneous puncture of the axillary artery. Value in arteriopathies of the lower limbs]. Arch Mal Coeur Vaiss 1984 0.75
110 [Implantable defibrillators. Good cost-effectiveness or supplementary expense to our hospitals?]. Arch Mal Coeur Vaiss 1999 0.75
111 [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications]. Arch Mal Coeur Vaiss 1980 0.75
112 ["Habitual" left branch block alternating with 2 "disguised" bracnch block]. Arch Mal Coeur Vaiss 1976 0.75
113 Long-term follow-up after surgical correction of the partial form of common atrioventricular canal (ostium primum). J Thorac Cardiovasc Surg 1974 0.75
114 Transient left anterior hemiblock during angina pectoris: coronarographic aspects and clinical significance. Eur J Cardiol 1979 0.75
115 [Electrophysiologic evaluation and follow-up of patients with a syncopal episode of unknown origin]. Arch Mal Coeur Vaiss 1990 0.75
116 [How to evaluate a conduction disorder?]. Presse Med 1984 0.75
117 Alternate ventriculo-atrial Wenckebach conduction during ventricular tachycardia. Pacing Clin Electrophysiol 1985 0.75
118 Pure left anterior hemiblock: hemodynamic and arteriographic aspects in patients with coronary artery disease. Eur J Cardiol 1978 0.75
119 [Internal electric shock: a new possibility for the reduction of permanent auricular fibrillation]. Presse Med 1987 0.75
120 The specific antigen(s) of cells in culture. Ann Immunol (Paris) 1975 0.75
121 [Rare indications for cardiac pacemakers (particularly the use of pacers in rapid rhythm disorders]. Rev Prat 1982 0.75
122 [Treatment of recurrent ventricular tachycardias using oral propafenone]. Arch Mal Coeur Vaiss 1985 0.75
123 [Sinus dysfunction associated with catecholaminergic ventricular tachycardia. Therapeutic implications]. Arch Mal Coeur Vaiss 1986 0.75
124 [Sinus arrest: severe complication of intravenous lidocaine]. Arch Mal Coeur Vaiss 1975 0.75
125 Left ventricular pressure measurement during noninvasive transcutaneous cardiac pacing. Pacing Clin Electrophysiol 1989 0.75
126 Inhibition of Na,K-ATPase by external electrical cardioversion in a sheep model of atrial fibrillation. J Cardiovasc Electrophysiol 2000 0.75
127 [Letter: Fenoxedil chlorhydrate in the treatment of arrhythmias]. Nouv Presse Med 1975 0.75
128 [Use of bretylium tosylate in the prevention of the rhythm disorders of myocardial infarct]. Arch Mal Coeur Vaiss 1971 0.75
129 [Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension]. Arch Mal Coeur Vaiss 1993 0.75
130 [Alternating Wenckeback phenomenon occurring in the same conduction tissue structure]. Arch Mal Coeur Vaiss 1980 0.75
131 [Ventricular tachycardia. A possible complication of intravenous atropine in the coronary patient]. Arch Mal Coeur Vaiss 1980 0.75
132 [Cardioversion by external electric shock for atrial fibrillation: does patient age affect immediate results?]. Arch Mal Coeur Vaiss 2002 0.75
133 [Ventricular tachycardia: definitions, mechanisms and treatment]. Rev Prat 1986 0.75
134 [Percutaneous aortic valvuloplasty by trans-septal approach]. Arch Mal Coeur Vaiss 1987 0.75
135 Canine cardiac digitalis receptors are preserved in congestive heart failure induced by rapid ventricular pacing. J Recept Signal Transduct Res 1997 0.75
136 [The role of beta-blocking agents in the treatment of cardiac dysrhythmia (author's transl)]. Ann Cardiol Angeiol (Paris) 1976 0.75
137 Should premature ventricular contractions be treated? If so, how? Panel Discussion I. Cardiology 1982 0.75
138 Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1996 0.75
139 [Cardioversion of atrial fibrillation with low energy internal electric shock]. Arch Mal Coeur Vaiss 1997 0.75
140 [Peroperative sinus arrest in a patient with sick sinus syndrome (apropos of a case)]. Ann Anesthesiol Fr 1977 0.75
141 [Monitoring of hemostasis during liver transplantation: contribution of thromboelastography]. Ann Fr Anesth Reanim 1993 0.75
142 [Relations between the site of significant monotruncular coronary stenosis and left ventricular function. Therapeutic implications]. Arch Mal Coeur Vaiss 1983 0.75
143 [Long-term follow up of surgically-treated congenital heart disease: interauricular communication, aortic coarctation, tetralogy of Fallot]. Ann Cardiol Angeiol (Paris) 1983 0.75
144 Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias. Cardiovasc Drugs Ther 1995 0.75
145 Acute thromboembolism associated with dissecting aneurysm of the aorta; two case reports. J Thorac Cardiovasc Surg 1973 0.75